Norouzi Somaye, Sarkohi Zahra, Alizadeh Leila, Ahmadian Leila
Non-Communicable Diseases Research Center Sabzevar University of Medical Sciences Sabzevar Iran.
Student Research Committee, Faculty of Management and Medical Information Sciences Kerman University of Medical Sciences Kerman Iran.
Health Sci Rep. 2025 Jul 11;8(7):e70980. doi: 10.1002/hsr2.70980. eCollection 2025 Jul.
Pediatric and neonate medication safety is a major issue. Children are at a higher risk of adverse drug events and medication errors than adults. As the mediation administration is the final stage of protection to impede potential unintentional adverse effects on patients. Thus, there is a strong need for research to explore new ways of reducing medication administration errors and time to calculate medication dosage in the pediatric and neonatal context. The objective is to assess the effectiveness of the Medication Administration Clinical Decision Support Systems (MACDSS) compared to the traditional method in a simulated environment for pediatric and neonatal care.
An open-label (unmasked), two-treatment, two-period, cross-over randomized controlled trial will be conducted in pediatric and neonatal settings with simulated scenarios to assess time to calculate medication dosage and medication administration errors with the MACDSS application compared to the traditional method. This study will recruit 16 participants randomly (1:1) from the Afzali-poor hospital in Kerman. The participants are supposed to perform nine highly realistic scenarios, three at a high level of complexity, three at a medium level, and three simple scenarios. For the cross-over stage, different scenarios at the same level of complexity will be presented. The main outcome will be the time spent to calculate the drug dosage by the nurse.
Developing a MACDSS as a mobile application may significantly improve the time needed to calculate dosage or amount and lower medication administration errors. If this application proves to be effective, it can be a very cost-effective means of improving outcomes in the medication administration process, positively affecting many pediatrics and neonates' patients.
Irct.behdasht.gov.ir, ID: IRCT20240409061457N1 registered on June 22, 2024.
儿科和新生儿用药安全是一个重大问题。儿童发生药物不良事件和用药错误的风险高于成人。由于药物管理是防止对患者产生潜在无意不良影响的最后一道保护防线。因此,迫切需要开展研究,探索在儿科和新生儿护理环境中减少用药错误和计算用药剂量时间的新方法。目的是在儿科和新生儿护理的模拟环境中,评估用药管理临床决策支持系统(MACDSS)与传统方法相比的有效性。
将在儿科和新生儿科室进行一项开放标签(非盲法)、双治疗、两阶段、交叉随机对照试验,通过模拟场景评估与传统方法相比,使用MACDSS应用程序计算用药剂量的时间和用药错误情况。本研究将从克尔曼的阿夫扎利贫困医院随机招募16名参与者(1:1)。参与者需完成九个高度逼真的场景,其中三个为高复杂程度,三个为中等复杂程度,三个为简单场景。在交叉阶段,将呈现相同复杂程度的不同场景。主要结果将是护士计算药物剂量所花费的时间。
开发作为移动应用程序的MACDSS可能会显著缩短计算剂量或用量所需的时间,并减少用药错误。如果该应用程序被证明是有效的,它可能是一种非常经济高效的方法,可改善用药管理过程中的结果,对许多儿科和新生儿患者产生积极影响。
Irct.behdasht.gov.ir,ID:IRCT20240409061457N1,于2024年6月22日注册。